Lipella Pharms Inc (LIPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 136 | 146 | 121 | 104 | 107 |
| Gross Profit | 136 | 146 | 121 | 104 | 107 |
| Operating Expenses | 1,089 | 1,364 | 850 | 1,461 | 1,682 |
| Operating Income | -952 | -1,218 | -730 | -1,357 | -1,575 |
| Interest Expense | 0 | 0 | 0 | 0 | 6 |
| Other Income | 14 | 26 | 41 | 33 | 42 |
| Pre-tax Income | -938 | -1,192 | -689 | -1,324 | -1,539 |
| Net Income Continuous | -938 | -1,192 | -689 | -1,324 | -1,539 |
| Net Income | $-938 | $-1,192 | $-689 | $-1,324 | $-1,539 |
| EPS Basic Total Ops | -0.99 | -1.31 | -0.64 | -1.84 | -2.16 |
| EPS Basic Continuous Ops | -0.99 | -1.31 | -0.69 | -1.84 | -2.14 |
| EPS Diluted Total Ops | -0.99 | -1.31 | -0.64 | -1.84 | -2.16 |
| EPS Diluted Continuous Ops | -0.99 | -1.31 | -0.69 | -1.84 | -2.14 |
| EPS Diluted Before Non-Recurring Items | -0.96 | -1.28 | -0.72 | N/A | N/A |
| EBITDA(a) | $-952 | $-1,217 | $-729 | $-1,357 | $-1,575 |